QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

WVE

QT49Wave Life Sciences Ltd.
NASDAQ·Healthcare·Biotechnology·SG
Latest market price
6.16
+0.21+3.53%
OverviewShort InterestFilings
WVEQT49Wave Life Sciences Ltd.·NASDAQ
OverviewShort InterestFilings
6.16+3.53%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.06
Insider Own39.43%
Shs Outstand192.40M
Perf Week6.02%
Market Cap1.14BForward P/E-EPS next Y-1.27Insider Trans4.57%Shs Float-Perf Month0.33%
Enterprise Value615.92MPEG0.11EPS next Q-0.31Inst Own-Short Float-Perf Quarter-49.17%
Income-176412617.00P/S15.94EPS this Y-2.18%Inst Trans-Short Ratio-Perf Half Y-62.46%
Sales71.80MP/B2.33EPS next Y-17.72%ROA-31.46%Short Interest-Perf YTD-63.76%
Book/sh2.66P/C-EPS next 5Y-ROE-56.41%52W High21.73 -71.65%Perf Year-6.53%
Cash/sh2.83P/FCF-EPS past 3/5Y-ROIC-36.32%52W Low5.02 22.71%Perf 3Y-
Dividend Est.-EV/EBITDA-3.53Sales past 3/5Y120.70% 16.54%Gross Margin93.79%Volatility2.81% 3.52%Perf 5Y-
Dividend TTM-EV/Sales8.58EPS Y/Y TTM-51.43%Oper. Margin-274.21%ATR (14)0.35Perf 10Y-
Dividend Ex-Date-Quick Ratio11.26Sales Y/Y TTM-33.33%Profit Margin-255.70%RSI (14)47.82Recom1.90
Dividend Gr. 3/5Y-Current Ratio11.26EPS Q/Q55.17%SMA202.01%Beta1.35Target Price20.29
Payout0.00%Debt/Eq0.03Sales Q/Q322.22%SMA50-7.91%Rel Volume1.30Prev Close5.95
Employees287LT Debt/Eq0.02EarningsJul 30SMA200-37.10%Avg Volume3.91MPrice6.16
IPO DateNov 11, 2015Option/ShortYes / YesEPS/Sales Surpr.61.76% 375.00%Net Debt/EBITDA3.03Volume5,070,080Change3.53%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26ReiteratedNew Street$13
May-20-26ReiteratedWells FargoOverweight$13 → $14
May-19-26ReiteratedH.C. WainwrightBuy$18 → $13
Apr-29-26ReiteratedTruist Financial$50 → $15
Apr-14-26ReiteratedH.C. WainwrightBuy$30 → $18
Mar-27-26ReiteratedWells FargoOverweight$27 → $13
Mar-26-26ReiteratedJefferiesBuy$28 → $18
Feb-12-26ReiteratedWells FargoOverweight$29 → $27
Feb-03-26ReiteratedCanaccord GenuityBuy$40 → $43
Feb-02-26ReiteratedRaymond JamesStrong Buy$21 → $26
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue7243108
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A490
Gross Profit6834108
Selling, General and Administrative Excl. Other797559
Research and Development189183160
Other Operating Expense-4-90
Operating Income-196-215-110
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-13-11-13
Net Income Before Taxes-183-204-97
Income Taxes000
Consolidated Net Income-183-204-97
Net Income From Continuing Operations-183-204-97
Net Income-183-204-97
EPS (Recurring)-1.06-1.21-0.70
EPS (Basic, Before Extraordinaries)-1.06-1.21-0.70
EPS (Diluted)-1.06-1.21-0.70
EBITDA-175-196-88
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio17.1166.81—
Gross Margin94.4479.07100.00
Operating Margin-272.22-500.00-101.85
Net Margin-254.17-474.42-89.81
Shares Outstanding200169138
Market Capitalization1,2322,873—
Operating Lease Expense
———
Insider Trading Volume
$6.43$5.99$5.55$5.11$4.67● Close Price0.00M13.66M27.31M40.97M54.62MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner:Mar 30 '26Buy6.50971,0916,312,09226,975,505Mar 30 12:00 AM
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner:Mar 27 '26Buy6.432,495,62316,046,85626,004,414Mar 30 12:00 AM
RA CAPITAL MANAGEMENT, L.P.director, 10 percent owner:Mar 26 '26Buy6.085,305,78232,265,43023,508,791Mar 30 12:00 AM
Francis ChrisSee RemarksFeb 26 '26Option Exercise4.2866,388283,840143,200Feb 27 12:00 AM
Francis ChrisSee RemarksFeb 26 '26Sale15.0533,194499,59361,867Feb 27 12:00 AM
Vargeese ChandraSee RemarksFeb 09 '26Sale13.453,22843,417408,246Feb 11 12:00 AM
Francis ChrisSee RemarksFeb 09 '26Sale13.451,88325,32661,867Feb 11 12:00 AM
BOLNO PAULPresident and CEOFeb 09 '26Sale13.4510,480140,956275,520Feb 11 12:00 AM
Moran KyleChief Financial OfficerFeb 09 '26Sale13.453,58848,259134,385Feb 11 12:00 AM
Francis ChrisSee RemarksJan 02 '26Sale16.039,375150,26125,000Jan 06 12:00 AM
Francis ChrisSee RemarksJan 02 '26Option Exercise3.1418,75058,87634,375Jan 06 12:00 AM
GSK plc10% OwnerDec 11 '25Buy19.001,470,00027,930,00018,245,691Dec 15 12:00 AM
Moran KyleChief Financial OfficerDec 09 '25Option Exercise9.5186,000818,120139,218Dec 10 12:00 AM
Moran KyleChief Financial OfficerDec 09 '25Sale20.0350,0361,001,97989,218Dec 10 12:00 AM
Francis ChrisSee RemarksDec 08 '25Option Exercise4.78882,0624,214,368161,100Dec 10 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR